Genmab — April 2015
-
De styrer festen.
-
God påske.

-
Her fascinating speech entitled: Targeting Solid Cancers Using Antibody-Drug Conjugates against the Novel ADC Targets Tissue Factor and Axl will explore topics such as:
Tissue factor (TF) as a target for an antibody-drug conjugate
Preclinical efficacy of HuMax-TF-ADC in a broad range of solid cancer xenograft models
Imaging HuMax-TF-ADC in cynomolgus monkeys
Axl as a novel ADC target -

-
God morgen.

-
Denne video fra Hans-Henrik er faktisk ikke så tosset i relation til kursbevægelserne i Genmab: http://www.proinvestor.com/?p=debat_1&postid=72060&thread=50&start=#72062
-
Har vi så 4 phase III i gang Gentogen? Det er kun 1.000 personers VTD studiet som mangler? jeg kan slet ikke finde dette på CT endnu?
-
og NHL studiet er der heller ikke endnu
-
Novod er vild for tiden. Han hæver jo nærmest kursmået hver uge pt.
-
Flere analytikere har nu bluesky over kurs 1.000
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind